Neurol. praxi. 2012;13(4):195-197

Congenital muscular dystrophies

assoc.prof.Jiří Vajsar MD, MSc, FRCPC1, MUDr.Josef Kraus, CSc.2
1 Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada
2 Klinika dětské neurologie, UK 2. LF a FN Motol, Praha

Congenital muscular dystrophies are genetic muscle diseases. They present with early hypotonia and muscle weakness. The muscle

biopsy is characterized by dystrophic or myopathic changes. There are several subtypes of congenital muscular dystrophy. The vast

majority of the diagnoses are confirmed by molecular testing or by immunohistochemistry. Treatment is symptomatic, interdisciplinary.

Genetic counselling should be available for teenagers and families.

Keywords: congenital muscular dystrophy, classification, immunohistochemistry, gene mutation

Published: July 31, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vajsar FRCPC J, Kraus J. Congenital muscular dystrophies. Neurol. praxi. 2012;13(4):195-197.
Download citation

References

  1. Bönnemann CG. Congenital Muscular Dystrophy. Encyclopedia of Neuroscience 2009; 3: 67-74. Go to original source...
  2. Godfrey C, Clement E, Mein R, Brockington M, Smith J, Talim B, Straub V, Robb S, Quinlivan R, Feng L, Jimenez-Mallebrera C, Mercuri E, Manzur AY, Kinali M, Torelli S, Brown SC, Sewry CA, Bushby K, Topaloglu H, North K, Abbs S, Muntoni F. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 2007; 130: 2725-2735. Go to original source... Go to PubMed...
  3. Lommel M, Cirak S, Willer T, Hermann R, Uyanik G, van Bokhoven H, Körner C, Voit T, Barić I, Hehr U, Strahl S. Correlation of enzyme activity and clinical phenotype in POMT1-associated dystroglycanopathies. Neurology 2010; 74: 157-164. Go to original source... Go to PubMed...
  4. Mostacciuolo ML, Miorin M, Martinello F, Angelini C, Perini P, Trevisan, CP. Genetic epidemiology of congenital muscular dystrophy in a sample from the north-east Italy. Hum Genet 1996; 97: 277-279. Go to original source... Go to PubMed...
  5. Muntoni F, Guicheney P, Voit T. 158th ENMC international workshop on congenital muscular dystrophy (Xth international CMD workshop) 8th-10th February 2008, Naarden, The Netherlands. Neuromuscul Disord 2009; 19: 229-234. Go to original source... Go to PubMed...
  6. Rankin J, Ellard S. The laminopathies: A clinical review. Clinical Genetics 2006; 70: 261-274. Go to original source... Go to PubMed...
  7. Scoto M, Cirak S, Mein R, Feng L, Manzur AY, Robb S, Childs AM, Quinlivan RM, Roper H, Jones DH, Longman C, Chow G, Pane M, Main M, Hanna MG, Bushby K, Sewry C, Abbs S, Mercuri E, Muntoni F. SEPN1-related myopathies: clinical course in a large cohort of patients. Neurology 2011; 76: 2073-2078. Go to original source... Go to PubMed...
  8. Vajsar J, Zhang W, Dobyns WB, et al. Carriers and patients with muscle-eye-brain disease can be rapidly diagnosed by enzymatic analysis of fibroblasts and lymphoblasts. Neuromuscul Disord 2006; 16: 132-136. Go to original source... Go to PubMed...
  9. Wang CH, Bönnemann CG, Rutkowski A, Sejersen T, Bellini J, Battista V, Florence JM, Schara U, Schuler PM, Wahbi K, Aloysius A, Bash RO, Béroud C, Bertini E, Bushby K, Cohn RD, Connolly AM, Deconinck N, Desguerre I, Eagle M, Estournet-Mathiaud B, Ferreiro A, Fujak A, Goemans N, Iannaccone ST, Jouinot P, Main M, Melacini P, Mueller-Felber W, Muntoni F, Nelson LL, Rahbek J, Quijano-Roy S, Sewry C, Storhaug K, Simonds A, Tseng B, Vajsar J, Vianello A, Zeller R. International Standard of Care Committee for Congenital Muscular Dystrophy. Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol 2010; 25: 1559-1581. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.